Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial-Reference-Cited by-同舟云学术

Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial

Published:2020-11-18 Issue:6 Volume:1 Page:1332-1340
ISSN:2688-1152
Container-title:Journal of the American College of Emergency Physicians Open
language:en
Short-container-title:Journal of the American College of Emergency Physicians Open

Author:

Guirgis Faheem W.¹,Black Lauren Page¹,DeVos Elizabeth¹,Henson Morgan¹,Ferreira Jason²,Miller Taylor¹,Rosenthal Martin³,Leeuwenburgh Christiaan⁴,Kalynych Colleen¹,Moldawer Lyle³,Jones Lisa²,Crandall Marie⁵,Reddy Srinivasa T.⁶,Gao Hanzhi⁷,Wu Sam⁷,Moore Frederick³

Affiliation:

1. Department of Emergency Medicine University of Florida College of Medicine–Jacksonville Jacksonville Florida USA

2. Division of Pulmonary and Critical Care Medicine Department of Medicine University of Florida College of Medicine–Jacksonville Jacksonville Florida USA

3. Department of Surgery University of Florida College of Medicine Gainesville Florida USA

4. Department of Aging and Geriatric Research University of Florida College of Medicine Gainesville Florida USA

5. Department of Surgery University of Florida College of Medicine–Jacksonville Jacksonville Florida USA

6. Department of Medicine UCLA College of Medicine Los Angeles California USA

7. Department of Biostatistics College of Public Health & Health Professions College of Medicine University of Florida Gainesville Florida USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emp2.12237

Reference50 articles.

1. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

2. Lipoproteins: Are they important components of host defense?

3. Thematic review series: The Pathogenesis of Atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host

4. Increased Plasma PCSK9 Levels Are Associated with Reduced Endotoxin Clearance and the Development of Acute Organ Failures during Sepsis

5. PCSK9 is a critical regulator of the innate immune response and septic shock outcome

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lessons From the LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P) Trial*;Critical Care Medicine;2024-07-15

2. The Lipid Intensive Drug Therapy for Sepsis Phase II Pilot Clinical Trial*;Critical Care Medicine;2024-03-15

3. Improving the usability of lipid emulsions and optimizing their user‐friendliness;The Japanese Journal of SURGICAL METABOLISM and NUTRITION;2024-02-15

4. Low circulatory levels of total cholesterol, HDL-C and LDL-C are associated with death of patients with sepsis and critical illness: systematic review, meta-analysis, and perspective of observational studies;eBioMedicine;2024-02

5. Association Between Hypocholesterolemia and Mortality in Critically Ill Patients With Sepsis: A Systematic Review and Meta-Analysis;Critical Care Explorations;2023-02-01